Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 54 (12%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-22 | 2020-02-07 | 99541 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-19 | 2020-03-24 | 106721 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-26 | 2020-04-08 | 109432 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144044 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144047 |
CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
CANDESARTAN | 4MG | TABLET | Resolved | 2017-06-14 | 2017-06-22 | 12745 |
CANDESARTAN | 4MG | TABLET | Resolved | 2018-09-07 | 2018-11-22 | 60200 |
CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
CANDESARTAN | 4MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96874 |
CANDESARTAN | 4MG | TABLET | Resolved | 2020-02-27 | 2020-03-27 | 107296 |
CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-04-09 | 2024-04-10 | 224727 |
CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96880 |
CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |